首页 | 本学科首页   官方微博 | 高级检索  
     

冠心病患者Fractalkine、单核细胞趋化蛋白-1和白细胞介素-8的检测及意义
引用本文:章春艳,曹政,杨勇,詹艳. 冠心病患者Fractalkine、单核细胞趋化蛋白-1和白细胞介素-8的检测及意义[J]. 蚌埠医学院学报, 2016, 41(4): 485-487. DOI: 10.13898/j.cnki.issn.1000-2200.2016.04.019
作者姓名:章春艳  曹政  杨勇  詹艳
作者单位:湖北省十堰市太和医院 心血管内科, 442000
摘    要:目的:探讨趋化因子Fractalkine、单核细胞趋化蛋白-1(MCP-1)和白细胞介素-8(IL-8)在不同类型冠心病(CHD)患者血清表达水平的变化及意义。方法:采集经冠状动脉造影确诊的稳定型心绞痛(SA)组患者48例、不稳定型心绞痛(UA)组患者56例、急性心肌梗死(AMI)组患者37例外周血标本,同期住院而冠状动脉造影正常的50例患者外周血标本作为对照组。采用酶联免疫吸附试验法检测4组血清Fractalkine、MCP-1和IL-8的表达水平,并以国际通用的Judkins法评估冠状动脉病变程度。结果:CHD患者血清Fractalkine、MCP-1和IL-8水平均明显高于对照组(P<0.01),UA和AMI组Fractalkine、MCP-1和IL-8水平均显著高于SA组(P<0.01);多支病变组和双支病变组Fractalkine、MCP-1和IL-8均明显高于单支病变组(P<0.01);重度狭窄组和中度狭窄组Fractalkine、MCP-1和IL-8水平亦显著高于轻度狭窄组(P<0.01)。结论:随着CHD患者病情的加重,血清趋化因子Fractalkine、MCP-1和IL-8水平明显升高,可用以评估CHD患者疾病的严重程度并监测疾病的进展情况。

关 键 词:冠心病   Fractalkine   单核细胞趋化蛋白-1   白细胞介素-8
收稿时间:2015-04-19

The serum level change of Fractalkine,monocyte chemotactic protein-1 and interleukin-8 in patients with coronary heart disease and its significance
ZHANG Chun-yan,CAO Zheng,YANG Yong,ZHAN Yan. The serum level change of Fractalkine,monocyte chemotactic protein-1 and interleukin-8 in patients with coronary heart disease and its significance[J]. Journal of Bengbu Medical College, 2016, 41(4): 485-487. DOI: 10.13898/j.cnki.issn.1000-2200.2016.04.019
Authors:ZHANG Chun-yan  CAO Zheng  YANG Yong  ZHAN Yan
Affiliation:Department of Cardiology, Taihe Hospital of Shiyan, Shiyan Hubei 442000, China
Abstract:Objective:To explore the serum levels change of Fractalkine,monocyte chemotactic protein-1(MCP-1) and interleukin-8 (IL-8) in patients with coronary heart disease(CHD) and its significance. Methods:After coronary angiography,48 stable angina patients,56 unstable angina patients,37 acute myocardial infarction( AMI) patients and 50 healthy people were divided into the SA, UA,AMI and control group,respectively. The serum levels of Fractalkine,MCP-1 and IL-8 in four groups were measured using enzyme-linked immunosorbent assay,and the severity of coronary artery disease was evaluated by Judkins method. Results:The serum levels of Fractalkine,MCP-1 and IL-8 in CHD patients were significantly higher than those in control group(P<0. 01),and the serum levels of Fractalkine,MCP-1 and IL-8 in UA and AMI group were significantly higher than those in SA group(P<0. 01). The serum levels of Fractalkine,MCP-1 and IL-8 in patients with double arteries and multiple arteries disease were significantly higher than those in patients with single artery disease(P<0. 01). The serum levels of Fractalkine,MCP-1 and IL-8 in patients with severe stenosis and moderate stenosis were significantly higher than those in patients with mild stenosis(P<0. 01). Conclusions:The CHD patient illness aggravates with the serum levels of Fractalkine,MCP-1 and IL-8 increasing,which can evaluate the severity and development of disease in CHD patients.
Keywords:coronary heart disease  Fractalkine  monocyte chemotactic protein 1  interleukin-8
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号